Cannabis company Althea surges higher on German expansion plans

The Althea Group Holdings Ltd (ASX:AGH) share price is surging higher this morning after announcing an expansion into the German cannabis market…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has surged higher following an announcement.

At the time of writing the cannabis company's shares are up 8% to 47 cents.

Why is the Althea share price charging higher?

Investors have been buying Althea's shares this morning after it announced plans to expand into the Germany market.

According to the release, Althea has signed a memorandum of understanding (MOU) with nimbus health for the sale and distribution of Althea's medicinal cannabis products in Germany through its pharmacy network.

Nimbus is a leading wholesale pharmaceutical licence holder based in Frankfurt, Germany. It specialises in the distribution and import of medicinal cannabis products and estimates that it has access to 25% of all German medicinal cannabis patients through its pharmacy network.

Althea anticipates the first shipment of its medicinal cannabis products arriving in Germany early in the first half of 2020. Relevant applications for import and export permits will be lodged now that the MOU has been executed.

What now?

In order to support its entry into the Germany market, Althea is following the same strategy that has been successfully implemented in Australia and the UK.

It will develop a localised version of its Althea Concierge platform and its Medicinal Education in Cannabinoids learning portal in Germany.

Thanks to these initiatives and Nimbus' strong market position, management believes it will be ideally positioned to compete in the German market and quickly build market share.

Which could potentially be very lucrative. The release advises that Prohibition Partners estimates that the German medical cannabis market will be worth €7.7 billion by 2028.

Althea CEO Josh Fegan said: "We are very pleased to have entered into this MOU with Nimbus. Working within an existing and successful distribution channel in Germany is a low risk and high reward strategy for us. The regulatory and social acceptance of medicinal cannabis use in Germany is favourable and we are expecting immediate patient growth in what is one of Europe's largest and most affluent countries."

Whilst this has the potential to be a big positive, I feel it is a little soon to get excited. Firstly, MOUs are not legally binding and, secondly, there is nothing to say that any deal will be exclusive.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »